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Encoded by the genome of most eukaryotes examined so far, microRNAs (miRNAs) are small ∼21-nucleotide (nt) noncoding
RNAs (ncRNAs) derived from a biosynthetic cascade involving sequential processing steps executed by the ribonucleases (RNases)
III Drosha and Dicer. Following their recent identiﬁcation, miRNAs have rapidly taken the center stage as key regulators of gene
expression. In this review, we will summarize our current knowledge of the miRNA biosynthetic pathway and its protein compo-
nents, as well as the processes it regulates via miRNAs, which are known to exert a variety of biological functions in eukaryotes.
Although the relative importance of miRNAs remains to be fully appreciated, deregulated protein expression resulting from either
dysfunctional miRNA biogenesis or abnormal miRNA-based gene regulation may represent a key etiologic factor in several, as
yet unidentiﬁed, diseases. Hence is our need to better understand the complexity of the basic mechanisms underlying miRNA
biogenesis and function.
Copyright © 2006 Dominique L. Ouellet et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
In 1990, a group of plant biologists attempted to accentuate
the purple pigmentation of petunia petals by increasing the
synthesis of anthocyanin via overexpression of a transgene
encodingchalconesynthase.Unexpectedly,thistransgenein-
duced the formation of white ﬂowers, in association with a
block in pigment synthesis and a 50-fold reduction in trans-
gene mRNA levels; this intriguing phenomenon was termed
cosuppression [1, 2].
Three years later, in the ﬁeld of developmental biology,
Lee et al [3] identiﬁed two lin-4 transcripts, with the smaller
(∼21nt) being complementary to seven repeated sequences
in the 3  nontranslated region (NTR) of the heterochronic
gene lin-14 mRNA, identiﬁed previously by Wightman et al
[4]. These ﬁndings suggested that lin-4 could regulate lin-14
translationviaanantisenseRNA:mRNAinteractionandplay
an important role in developmental timing in the nematode
Caenorhabditis elegans (C elegans) [3, 5].
These studies converged in 1998, when Fire et al [6]o b -
tained evidences about the involvement of double-stranded
(ds) RNA intermediates in a phenomenon termed RNA in-
terference (RNAi). The authors noticed that dsRNA species
induced a more potent genetic interference than either
strands alone in Ce l e g a n s . A year later, while investigating
posttranscriptional gene silencing (PTGS) as a natural an-
tiviraldefensemechanism,HamiltonandBaulcombe[7]o b-
servedthepresenceofantisenseviralRNAof ∼25ntinvirus-
infected plants. The authors noted that these small RNAs
were long enough to convey sequence speciﬁcity and sug-
gested that they may be important speciﬁcity determinants
of PTGS. Subsequent papers reporting that dsRNA-induced
mRNA degradation is mediated by 21 to 23nt RNAs [8, 9]
prompted molecular biologists and geneticists to search for
the endogenous source of small RNAs. In 2001, three inde-
pendent groups deﬁned miRNAs as a novel family of small
(∼22nt) endogenous RNAs that are diverse in sequence and
expression patterns, evolutionarily widespread, and involved
in sequence-speciﬁc, posttranscriptional regulatory mecha-
nisms of gene expression [10–12].
We now know that miRNA genes are encoded in the
genome of most eukaryotic organisms and transcribed
by RNA polymerase (pol) II into primary miRNAs (pri-
miRNAs). These structured RNAs are then processed by the
nuclear RNase III Drosha, acting in concert with the DiGe-
orge syndrome critical region 8 (DGCR8) protein within a2 Journal of Biomedicine and Biotechnology
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Figure 1: mRNA regulation mediated by microRNAs (miRNAs). miRNA genes are transcribed by RNA polymerase II into primary miRNAs
(pri-miRNAs), which are processed by Drosha, acting in concert with DiGeorge syndrome critical region 8 (DGCR8) protein within the
microprocessor complex, into ∼60 to 70nt miRNA precursors (pre-miRNAs). Following export via exportin-5, pre-miRNAs are cleaved by
Dicer, acting in concert with transactivating response RNA-binding protein (TRBP) within the pre-miRNA processing complex, to generate
an imperfect miRNA:miRNA∗ duplex of ∼21 to 23nt. After a strand selection/separation process, the mature miRNA is loaded into an
eﬀector miRNA-containing ribonucleoprotein (miRNP) complex that will recognize and mediate repression or cleavage of speciﬁc mRNAs.
Synthetic small interfering RNAs (siRNAs) can be introduced into cells and be incorporated into the endogenous miRNA-guided RNA
silencing machinery to mediate cleavage of the targeted mRNA.
complex known as the microprocessor [13–16], into ∼60
to 70nt stem loop miRNA precursors (pre-miRNAs) [17–
19]. Following export from the nucleus to the cytoplasm by
theRan-GTPdependenttransporterExportin-5[20–23],the
pre-miRNAs are cleaved at the base of the loop by a second
RNaseIIIenzymelocatedinthecytoplasm,Dicer,togenerate
an imperfect miRNA:miRNA∗ duplex of ∼21 to 24nt. Dicer
was recently shown to act together with the transactivating
response RNA-binding protein (TRBP) within a pre-miRNA
processing complex. Following strand selection/separation,
mature ∼22nt miRNAs are incorporated into, and guide, ef-
fector miRNA-containing ribonucleoprotein (miRNP) com-
plexes containing Argonaute 2 (Ago2) towards speciﬁc mR-
NAs. Dicer and TRBP have recently been shown to be a
part of a functional human RNA-induced silencing complex
(RISC), thereby coupling the initiation and eﬀector steps of
RNAi [24]. The targeted mRNA will be initially subjected
either to cleavage or translation repression, depending on
whether the miRNA:mRNA pairing is perfect or not [25].
The miRNA-guided RNA silencing pathway is illustrated in
Figure 1.
In humans, conservative predictions indicate that up to
30% of the genes may be regulated by such a mechanism!
Thus, potentially all the cellular pathways may be governed
by miRNAs, which may contribute to the ﬁne tuning of gene
expression on a global level. The importance of miRNAs in
gene regulation will be better appreciated when their func-
tion or deregulation, or that of the cellular machinery me-
diating their biosynthesis and function, will be identiﬁed
among the underlying causes of several genetic disorders. In-
deed, it is easy to conceive that protein overexpression re-
sulting from defective miRNA-based mRNA regulation may
compromise normal cell function and cause genetic diseases.
In turn, the responsible gene(s) may be responsive to RNAi-
based inactivation, illustrating the transition from funda-
mental research to clinical applications of RNAi.
Today,themiRNAmimeticssmallinterferingRNAs(siR-
NAs) are increasingly important molecular tools, as they of-
ten are the method of choice used by researchers that aim at
elucidating the function of a gene. More importantly, per-
haps, is the high potential of the approach for therapeu-
tic applications, leading several biotechnology ﬁrms to de-
velop and reﬁne tools, and improve the design of new ther-
apeutic strategies in order to take advantage of the natu-
ral RNA silencing machinery to silence the expression of
disease-causing genes. This requires a better understand-
ing of the miRNA-based RNA silencing machinery in hu-
man.Dominique L. Ouellet et al 3
COMPONENTS OF THE RNAi MACHINERY
The endogenous miRNA-guided RNA silencing machinery
is composed of several diﬀerent proteins, protein complexes,
and types of RNAs. How these elements integrate with each
other to form this important functional cascade is the sub-
ject of intense investigations. We will ﬁrst discuss the pro-
teincomponents,identiﬁedsofar,thataregoverningmiRNA
biogenesis and function (see Figure 1). The subsequent sec-
tions will cover the identiﬁcation of miRNAs and their tar-
gets, the biological roles of miRNAs, as well as their involve-
ment in diseases.
RNApolymeraseII
RNA pol II, which governs the transcription of protein-
encoding messenger RNAs (mRNAs), has been identiﬁed as
themajortranscriptionalunitformiRNAgenes[17,26]after
some speculations about the potential implication of RNA
pol III [25]. The pri-miRNA transcripts, which can be longer
than 1000nts [26] and up to several kilobases long, possess
the signature of RNA pol II characterized by a 5  7-methyl
guanylate (m7G) cap and a 3  poly(A) tail [17]. Although
miRNA genes can be found as clusters forming their own
transcriptional units [19, 26], ∼40% are transcribed from
the intronic sequence of protein-encoding genes [27, 28]. A
study by Rodriguez et al [27] has shown that the expres-
sion of a large subset of mammalian miRNAs may be tran-
scriptionally linked to the expression of other genes, cod-
ing for both proteins and ncRNAs. Although the majority of
pri-miRNAs are noncoding RNAs, whose genomic regions
do not correlate with known transcripts [29], some of them
contain open reading frame (ORF) susceptible to be trans-
lated. However, analysis of both endogenous and overex-
pressed pri-miRNAs showed that very little full-length pri-
miRNA transcripts reached the cytoplasm, probably because
theywereprocessedbyDroshabeforetheycouldbeexported
from the nucleus [17].
Drosha
The RNase III Drosha is a class II endoribonuclease that was
identiﬁed, cloned, and ﬁrst implicated in preribosomal RNA
(pre-rRNA) processing [30] (see Figure 2). Members of the
class II RNase III family are characterized by a duplication
of the RNase III domain (RIIID), a C-terminal dsRNA bind-
ing domain (dsRBD), as well as a proline-rich region (PRR)
and an arginine/serine(RS)-rich domain in the N-terminal
region [18, 30]. Previously known as the human RNase III,
Drosha was further identiﬁed as the enzyme mediating the
ﬁrst step in miRNA biogenesis through conversion of pri-
miRNAs into pre-miRNAs [18] (see Table 1), conﬁrming
previous ﬁndings obtained with nuclear fractions of human
cultured cells [19].
Drosha homologues are expressed in Ce l e g a n s[13, 31],
Drosophila melanogaster (D melanogaster)[ 13, 31], and
Mus musculus [32], but not in Schizosaccharomyces pombe
(Spombe)(http://www.sanger.ac.uk/Projects/S pombe/)and
Arabidopsis thaliana (A thaliana)[ 30]. The absence of
Drosha in lower species reveals fundamental diﬀerences in
the initiation steps of small regulatory RNA biosynthesis,
which may have been evolved during the course of evolution.
Pri-miRNA processing by Drosha yields a pre-miRNA
product with termini bearing the signature of RNases III,
that is, a 5  phosphate and 2nt overhangs at the 3  hydrox-
ylated end [18, 19, 33]. From the junction of the loop and
the adjacent stem, Drosha cleaves pri-miRNAs after approxi-
mately two helical turns into the stem to produce ∼70nt pre-
miRNAs [18]. Lee et al used deletional mutagenesis on miR-
30a followed by in vitro processing to show that sequences
covering ∼20nt upstream and ∼25nt downstream of the ex-
pected cleavage site were necessary and suﬃcient to support
processing [18]. Beyond the pre-miRNA cleavage sites, ap-
proximately one helix turn of stem extension is also essential
foreﬃcientprocessing.WhileDroshacleavagesitesaredeter-
mined largely by the distance from the terminal loop, varia-
tions in stem structure and sequence around the cleavage site
canﬁne-tunetheactualcleavagesiteschosen[34].Acleaving
model was proposed in which the two RIIID of Drosha form
anintramoleculardimertocreateacatalyticsiteforsubstrate
processing[15].Thismodelisanalogoustothatproposedfor
Dicer [35]. The two RIIIDs of human Drosha are distinct in
their roles within the dimer: the RIIIDa cuts the 3  strand,
while the RIIIDb cleaves the 5  strand, independently of each
other [15]. Han et al suggested that Drosha may reorientate
itself after the recognition of the 3  end of pri-miRNAs [15]
and, as for human Dicer, places the processing center at <20
base pairs from the terminus [35].
Fractionation of HEK 293 cell nuclear extracts by gel
ﬁltration chromatography identiﬁed a pri-miRNA process-
ing activity corresponding to a molecular mass of >700kDa
[15]. This activity peak shifted to <650kDa following treat-
ment of the extract with RNase A, indicating that Drosha
may function in a large complex of <650kDa. Analysis of
Drosha immunoprecipitates by mass spectrometry revealed
the presence of DGCR8 in that complex [13, 14]. A distinct,
larger Drosha complex containing the DEAD box RNA heli-
case DDX17/P72, the heterogeneous nuclear ribonucleopro-
teinM4(hnRNPM4),andtheproteinproductofEwing’ssar-
coma gene (EWS) was reported [14]. As reviewed in Arvand
and Denny [36] ,E W Sb e l o n g st oaf a m i l yo fg e n e st h a te n -
code proteins that may serve as adapters between the RNA
pol IIcomplexandRNAsplicing factors.BecauseDroshahas
also been previously shown to participate in pre-rRNA pro-
cessing[30],thislargeDroshacomplexhasbeensuggestedto
mediate such pre-rRNA processing activities [14].
DGCR8/microprocessor
DGCR8 was identiﬁed in anti-Flag immunoprecipitates pre-
pared from an HEK-293 cell line stably expressing Flag-
Drosha [14]. This Drosha-DGCR8 complex, which has also
been observed in other organisms [13, 16], has been termed
microprocessor [14]. DGCR8 contains two dsRBDs and
a WW domain that could interact with the N-terminal
proline-rich region of Drosha [14].4 Journal of Biomedicine and Biotechnology
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Figure 2: Some peculiarities of the major protein components of the microRNA-guided RNA silencing.
The exact role of DGCR8 in the microprocessor com-
plex remains uncertain, but may be related to pri-miRNA
recognition. In accordance with a proposed model, DGCR8
would interact with the stem, and perhaps also the single-
stranded (ss) region of this structure, to guide the recogni-
tion of the pri-miRNA stem by Drosha dsRBD. Alternatively,
but not exclusively, DGCR8 may also interact with the ss re-
gion of RNA to correctly orient the complex on pri-miRNAs
[15]. Gregory et al [14] have shown that the knock-down of
DGCR8resultsin,asobserveduponDroshadepletion,apro-
nounced decrease in mature miRNA level. Depletion of both
Drosha and DGCR8 resulted in a substantial accumulation
of pri-miRNAs, showing the requirement of the micropro-
cessor complex for miRNA processing in vivo [14].
TheDGCR8geneislocatedintheq11.2regionofthehu-
man chromosome 22 that contains ∼30 genes and is a part of
a common monoallelic deletion [37]. Patients carrying this
heterozygousdeletionandotherchromosomalabnormalities
in this region display clinical phenotypes deﬁned as the Di-
Georgesyndrome,Conotroncalanomalyfacesyndrome,and
Velocardiofacial syndrome [38]. Congenital heart defects,
characteristic facial appearance, immunodeﬁciency, and be-
havioral problems are other manifestations of these genetic
disorders [38].
Exportin-5
Subcellular localization studies previously showed that pri-
miRNA and pre-miRNA processing is compartmentalized
into the nucleus and cytoplasm, respectively [19], suggest-
ing the existence of a pre-miRNA nuclear export step. Less
than two years later, three independent groups reported the
identiﬁcation of Exportin-5, a member of the nuclear karyo-
pherin β transporter family [21], as the nuclear pre-miRNA
transporter [20, 22, 23].
Exportin-5-mediated pre-miRNA transport was either
reduced upon downregulation of Exportin-5 by siRNAs [23]
or enhanced upon overexpression in mammalian cells [39].
Export of pre-miRNAs was greatly reduced by the inhibition
of the Ran guanine nucleotide exchange factor, suggestingDominique L. Ouellet et al 5
Table 1: Characteristics of the major protein components of the miRNA-guided RNA silencing pathway.
Protein Role/
function
Accession
mRNA
(bp)
Accession
Amino
acids
Molecular
Isoelectric
point∗
Intracellular
localization number number weight
(mRNA) (protein) (kDa)∗
Drosha
Processing of
NM 013235 4764 NP 037367 1374 159 7.81 Nuclear pri-miRNA into
pre-miRNA
DGCR8
Assistance of Drosha
NM 022720 4461 NP 073557 773 86 5.94 Nuclear function in the
microprocessor
Exportin-5 Nuclear export NM 020750 5231 NP 065801 1204 136 5.79 Nuclear membrane
of pre-miRNA
Dicer Processing of pre-miRNA NM 177438 10 276 NP 803187 1922 219 5.68 Cytoplasmic, ER
into miRNA:miRNA∗
TRBP
Assistance of Dicer
M60801 1368 AAA36765 345 38 7.38 Cytoplasmic function in pre-miRNA
processing complex
Ago2 Component of miRNPs, NM 012154 3567 NP 036286 859 97 9.19 Cytoplasmic
repression of translation
FMRP Component of miRNPs, NM 002024 4362 NP 002015 632 71 7.42 Cytoplasmic,
repression of translation nuclear
∗Calculated from protein calculator v.3.2 (http://www.scripps.edu/∼cdputnam/protcalc.html). ER, endoplasmic reticulum.
t h a ti ti sc a t a l y z e db yR a n G T P[ 22]. In fact, RanGTP was
necessary for speciﬁc binding of pre-miRNAs by Exportin-
5[ 23]. Recognition of pre-miRNAs bearing a 2nt 3  over-
hang by Exportin-5 was superior than pre-miRNAs with 5 
or no overhangs [40]. As for the pre-miRNA terminal loop
and stem, which should be more than 16nt in length, their
recognition is not sequence-speciﬁc [20, 40]. Recognition of
a minihelix motif in the RNA allows transport by Exportin-
5, as demonstrated by the eﬃcient transport of VA1 RNA
from adenovirus 5 [41]. The exact coordination links be-
tween Exportin-5 and the nuclear and cytoplasmic steps of
miRNA biogenesis remain obscure and need further investi-
gation.
Dicer
Dicer is a ribonuclease III that was ﬁrst identiﬁed as an en-
zyme capable of generating ∼21–23nt RNA guide sequences
from dsRNA to initiate RNAi in Drosophila S2 cells [42].
Within a two-month period, three papers reported that null
mutationsintheDicergenealtereddevelopmentaltiming,in
association with defective miRNA maturation and accumu-
lation of pre-miRNAs, in Ce l e g a n s[43, 44]a n dDrosophila
[45]. Human Dicer cDNA, which had been identiﬁed two
years before [46], was later cloned and the recombinant pro-
teinexpressed,allowingthecharacterizationofitsRNAbind-
ing properties and RNase activity [47, 48]. Localized mainly
in the cytoplasm [49] or the endoplasmic reticulum [47]o f
cultured cells, human Dicer is a large protein composed of
several domains: an N-terminal putative ATPase/helicase do-
main containing a DECH box, a domain of unknown func-
tion (DUF283), a PIWI/Ago/Zwille (PAZ) domain, and a C-
terminal RIIID, composed of tandem RNase III motifs and a
C-terminal dsRBD [35, 42, 47, 48].
Recently, data reported by Zhang et al [35] pointed to-
wards the existence of a single catalytic center in human
Dicer. The authors proposed a model in which Dicer would
function through intramolecular dimerization of its two RI-
IID,assistedbytheﬂankingRNAbindingdomains,PAZ,and
dsRBD. The PAZ domain of Dicer may participate in the
recognition of the terminal 3  overhangs of its pre-miRNA
substrate [35]. In this model, each RIIID cuts a single strand
of the RNA duplex substrate after two turns of α-helices, at
the end opposite to that cleaved by Drosha, to produce a new
end bearing a hydroxylated 2nt 3  overhang and a phospho-
rylated 5  end. The 2nt overhang is measured by the align-
ment of the dimer rather than by the distance between ac-
tive residues on one peptide chain, whereas the length of the
product (∼21nt) is determined by the distance between the
PAZ domain and the active site [35].
Genetic studies revealed that Dicer is essential for mam-
malian development, as Dicer-deﬁcient mice die at the em-
bryonic stage [50, 51]. However, the DCR-1 gene can be dis-
rupted in mouse embryonic stem (ES) cells by conditional
gene targeting. The generated Dicer-null ES cells are viable,
despite being completely defective in the generation of miR-
NAs, and display severe defects in diﬀerentiation both in
vitro and in vivo [52]. Similar conditional inactivation of the
Dicer gene in ES cell lines compromised proliferation as well
as miRNA maturation, possibly rationalizing the phenotype6 Journal of Biomedicine and Biotechnology
observed in Dicer-null animals [53]. Epigenetic silencing of
centromeric repeat sequences [52, 53] and expression of ho-
mologous small dsRNAs [52] were also markedly reduced in
Dicer-null ES cells. Re-expression of Dicer in knockout cells
rescued these phenotypes [52]. These results suggest the in-
volvement of Dicer in multiple fundamental biological pro-
cesses in mammals, ranging from stem cell diﬀerentiation to
maintenance of centromeric heterochromatin structure and
centromeric silencing [52].
It is relevant to note that Dicer activity is potently stim-
ulated by limited proteolysis induced by low concentrations
of proteinase K in vitro [47, 48], indicating the presence of
intrinsic regulatory domains of Dicer activity. As recently
reported, cellular proteins interacting with Dicer such as
Ago2 [54],fragileXmentalretardationprotein(FMRP)[55],
TRBP[56,57],andtheproteinkinaseR(PKR)-activatingen-
zyme (PACT) [58] may also represent key regulators of Dicer
activity. In addition, Dicer was recently shown to be a part of
an eﬀector miRNP [24], thereby coupling the initiation and
eﬀector steps of miRNA-guided RNA silencing.
TRBP
TRBP was identiﬁed and characterized in 1991 as a cellu-
lar factor acting in synergy with the viral Tat protein in the
transactivation of the long terminal repeat (LTR) of human
immunodeﬁciencyvirustype1(HIV-1),leadingtoviralgene
transcription [59]. TRBP exists mainly in two diﬀerent iso-
forms: TRBP1 and TRBP2 [60], which possess three dsRBDs
and a basic C-terminus, coexist in the cell and are encoded
by two alternatively initiated isoforms of mRNA that diﬀer at
their 5  ends. TRBP2 is 21 amino acids longer than TRBP1
[60–62]. TRBP has also been shown to bind Tax of human
T-cell leukemia virus 1, although this interaction inhibits
the transactivating activity of Tax [63]. Another function of
TRBP is the inhibition of the interferon-induced dsRNA-
regulated PKR [64].
Recently, TRBP has been reported to play a role in
miRNA-guided RNA silencing. TRBP was identiﬁed by pro-
teomic analysis of immunoprecipitates prepared from HEK
293-derived stable cell lines expressing a Flag-tagged Dicer
[56]. Further analyses revealed the association of Dicer-
TRBP with Ago2 and the requirement of TRBP for the re-
cruitment of Ago2 to the siRNA bound by Dicer. TRBP was
shown to facilitate the cleavage of pre-miRNAs in vitro and
optimize RNA silencing mediated by siRNAs and endoge-
nousmiRNAs[57].TheseresultssupportaroleforTRBP,the
ﬁrstDicer-interactingproteinidentiﬁedsinceAgo2,inassist-
ing Dicer function in a pre-miRNA processing complex and
contributing to RISC assembly by the recruitment of Ago2 to
the miRNA.
A Dicer interaction with the Drosophila homologue of
human TRBP, Loquacious (Loqs), which share 34% iden-
tity at the amino acid level, was also observed by two in-
dependent groups [65, 66]. As for human TRBP, Loqs was
required for normal processing of pre-miRNAs by Dicer-1
[65, 66]a n df o re ﬃcient miRNA-mediated silencing in vari-
ous contexts [65]. Thus, every known ﬂy RNase III is paired
with a dsRBD-containing protein that facilitates its function
in small RNA biogenesis.
R2D2
The siRNA-generating complex puriﬁed from Drosophila S2
cells consists of two stoichiometric subunits: Dicer-2 and
R2D2 [67]. R2D2, which was named so because it con-
tains two dsRNA-binding domains (R2) and is associated
with DCR-2 (D2) in Drosophila [67], is homologous to C
elegans RDE-4 [68, 69]. The Dicer-2/R2D2 complex, but
not Dicer-2 alone, binds to siRNA and enhances sequence-
speciﬁc mRNA degradation mediated by the RISC. R2D2
has been shown to act as a biosensor for detecting thermo-
dynamic diﬀerences of base pairing at the extremities of an
siRNA [70]. Thus, in concert with Dicer-2, R2D2 determines
which siRNA strand will be incorporated into the RISC and
may also discriminate an impostor siRNA [71, 72]. These re-
sults indicate that R2D2 bridges the initiation and eﬀector
steps of the Drosophila RNAi pathway by facilitating siRNA
passage from Dicer to RISC. Whether a similar mechanism is
operating in humans remains to be investigated.
RISCandmiRNPs
ThemiRN AorsiRN AgeneratedbyDicerisloadedintoanef-
fector miRNP or siRNP complex, respectively, and guides it
for the recognition and regulation of the mRNA target. The
mRNAspeciﬁcallyrecognizedbytheRNPcomplexeswillini-
tially be either cleaved or translationally repressed, depend-
ing on whether the guide:mRNA pairing is perfect or not
[25]. In humans, mRNA regulation by miRNAs is believed to
consist mainly in translational repression, although a recent
study reported that miRNAs downregulate a greater number
of transcripts than previously thought [73]. Yekta et al [74]
demonstrated that miR-196 shows perfect complementarity
(presence of a single G:U wobble) with HOXB8 mRNA and
directs its cleavage in mouse embryos. Genes for miR-196
map to homeobox (HOX) clusters, which encode transcrip-
tion factors crucial for the developmental program in ani-
mals.Baggaetal [75]observedthatthelet-7miRNAinduces
degradation of its target, lin-41, in Ce l e g a n s . Furthermore,
they observed that the level of the lin-4 miRNA targets, lin-
14 and lin-28, is decreased in response to lin-4 expression.
These observations suggest that mRNAs containing partial
miRNA complementary sites may not only be subjected to
translational repression, but also be targeted for degradation
in vivo.
Initial studies on the RISC reported the existence of a
large (∼150kDa to ∼500kDa) multiprotein RNP complex
exhibiting sequence-speciﬁc nuclease activity [54, 76, 77].
S m a l lR N A so f∼21 to 25nt were found to copurify with the
RISC isolated from Drosophila S2 cells [76], a characteristic
shared by RISC complexes from other species [78]. A study
by Pham et al [78] provided the ﬁrst glimpse of the mech-
anism involved in RISC assembly. The authors proposed a
three-stepmodelforRISCformationinDrosophila.Isolation
of three distinct complexes, named R1, R2, and R3, by native
gel electrophoresis showed that siRNA binding to Dicer-2 isDominique L. Ouellet et al 7
responsible for R1 formation. R1 is probably the ∼360kDa
complex described as the RISC [77]. R1 serves as a precursor
to form both the R2 and R3 complexes. R3 is a large ATP-
enhanced complex that contains unwound siRNAs, cofrac-
tionateswithknownRNAifactors,bindsandcleavestargeted
mRNAs in a cognate siRNA-dependent manner [78].
Recently, three studies published in the same issue of Cell
[24, 79, 80] provided additional insights on the composi-
tion, assembly, and function of the RISC. Gregory et al [24]
showed that the human RISC is composed of at least three
proteins: Dicer, TRBP, and Ago2. Recently, the dsRBD pro-
teinPACTwasalsofoundtobeassociatedwithDicer,hAgo2,
and TRBP in a ∼500kDa complex and to function as a com-
ponent of the RISC [58]. At ﬁrst, an ATP-dependent heli-
case was proposed to separate the two siRNA strands, one of
which was thought to bind to Ago2. However, a recent con-
sensus model suggests that Ago2 directly receives the double-
stranded siRNA and cleaves the siRNA passenger strand in-
stead, thereby liberating the ss guide for mediating cleav-
age or repression of the RNA target [24, 79, 80]. In con-
trast, passenger-strand cleavage is not important for the in-
corporation of miRNAs that are derived from mismatched
duplexes, suggesting that this mechanism may not apply to
endogenous miRNAs in humans.
In 2002, Mourelatos et al [81] reported the identiﬁca-
tion and characterization of a miRNP complex showing high
similarity with the RISC. The authors isolated a wide range
of diﬀerent miRNAs forming a complex with three major
proteins: Gemin3, Gemin4, and EIF2C2 (hAgo2). Gemin3,
a 105kDa DEAD-box putative helicase, may be involved in
unwinding the double-stranded miRNA and releasing the
miRNA∗ strand for recognition of the target.
P-/GW-bodies
Where does the miRNP-mediated mRNA regulation or
cleavage occur in the cell? Recent studies revealed the ex-
istence of speciﬁc cytoplasmic foci, referred to as process-
ing (P-bodies) [82, 83] or GW182-containing bodies (GW-
bodies) [84] .T h eG Wb o d i e s ,w h i c hw e r en a m e ds ob e c a u s e
they contain the GW182 RNA-binding protein, are enriched
in proteins that are involved in mRNA degradation [85]. Liu
et al [82] demonstrated the localization of Ago proteins into
mammalian P-bodies. In fact, Ago proteins were found to in-
teract with GW182 [86]. Silencing of GW182 or mutations
thatpreventedAgoproteinsfromlocalizinginP-/GW-bodies
impaired translational repression of mRNAs [86]. The pres-
ence of exogenous siRNAs was also detected in these bod-
ies [87]. These studies support a functional link between cy-
toplasmic P-/GW-bodies and mRNA translation repression
mediated by miRNAs.
These cytoplasmic P-/GW-bodies may not be the only
sites of mRNA degradation in the cell. Two independent
groups also detected a RISC-like activity in the nucleus of
cultured mammalian cells [88, 89]. It is tempting to specu-
late that the nuclear eﬀector complex mediating this activity
may be closely related to the RNA-induced initiation of tran-
scriptional gene silencing (RITS) complex found in Sp o m b e
[90].
Ago2
Ago2 is a member of the PAZ and Piwi domain (PPD) pro-
tein family, which is composed of highly basic proteins that
are present in metazoans and fungi, but not in the budding
yeast Saccharomyces cerevisiae [91, 92]. Eight members of
the Ago family are expressed in humans [93], and the iso-
forms Ago1 to 4 are closely related. All four can bind siRNAs
and miRNAs, but only Ago2 is present in an mRNA-cleavage
competent RISC [94, 95]. Several paralogues of Ago proteins
are found across the kingdoms and their number varies from
1i nSp o m b e[96]t om o r et h a n2 0i nCe l e g a n s[43, 97].
Structural studies have provided key insights into the
mechanism of RNAi. Ago2 is composed of a central PAZ
domain and a C-terminal PIWI domain. The nuclear mag-
netic resonance solution structure of the Drosophila Ago1
PAZ domain bound to RNA was resolved recently [98, 99].
The structure consists of a left-handed, six-stranded β-barrel
capped at one end by two α-helices and wrapped on one side
byadistinctiveappendage,whichcomprisesalongβ-hairpin
and a short α-helix. Combined structural and binding stud-
ies of the PAZ domain indicated that it provides a binding
pocket for the 3  protruding ends of siRNAs [98–101].
Structural studies revealed that the PIWI domain con-
sistsof5-strandedβ-sheetssurroundedbythreehelices[102]
and mediates binding of the ss RNA 5  end [103–105]. The
structure of Archaeoglobus fulgidus PIWI domain in complex
with an siRNA-like duplex, which mimics the 5  end of a
guide RNA strand bound to an overhanging target mRNA,
has been solved. This study revealed the presence of a highly
conserved metal-binding site that anchors the 5  nt of the
guideRNA[105].StructuralstudiesalsodeterminedPIWIas
the catalytic domain for the nuclease activity of Ago2, given
its resemblance to RNase H [95, 102, 104], in terms of struc-
tureandactivity;likeRNaseH,Ago2activityisdependenton
divalent cations such as Mg2+ or Mn2+ [106] .T h eP I W Id o -
main and RNase H also share a DDE motif, similar to those
present at the catalytic center of integrase proteins [107].
Structural information from Pyrococcus furiosus Ago
[102], together with the demonstration that Ago2 is the
core slicing machine of the human RISC [95, 108], provided
strong evidences suggesting that the PIWI domain may be
responsible for mediating this “slicer” activity. This possibil-
itywasfurthersupportedbytheobservedinhibitionoftarget
mRNA cleavage activity upon deletion of the DDE motif of
hAgo2[95].InsiRNA-guidedRNAsilencing,Ago2cleaves,in
an ATP-independent manner, the phosphodiester backbone
of the target mRNA between nucleotides 10 and 11, as calcu-
lated from the RNA guide 5  end [80, 94, 109].
The mechanism of translation repression mediated by
Ago proteins is still unclear, although recent evidences sug-
gest the possibility that some Ago-containing complexes may
repress translation in P-bodies [110, 111].
FMRP
In human, loss-of-function mutations in the FMR1 (fragile
mental retardation 1) gene product FMRP is the cause of the
most common mental retardation, the fragile X syndrome8 Journal of Biomedicine and Biotechnology
[112, 113]. An expansion of the CGG repeat in the 5 NTR
of FRM1 is associated with DNA methylation problems of
both the CpG island and the CGG repeat itself, resulting in
an inhibition of transcription and translation [114, 115].
FMRP is a cytoplasmic RNA-binding protein found to
be associated with polyribosomes as part of an mRNA ri-
bonucleoprotein (mRNP) complex, suggesting a role for
FMRP in mRNA translation regulation [112]. In fact, this
protein of 632 amino acids, containing two K-homology
(KH) domains and an RGG box, acts as a negative regu-
lator of translation in vitro and in vivo [116–118]. A re-
lationship between FMRP and the RNAi pathway was un-
veiled by the copuriﬁcation of dFMR1 with the Drosophila
RISC, which also contains Ago2 and the vasa intronic gene
(VIG) [119]. Similarly, Ishizuka et al [55] used a tan-
dem aﬃnity puriﬁcation approach to isolate an RNP com-
plex that contains dFMR1, Ago2, the RNA helicase Dmp68,
and the ribosomal proteins L5/5S RNA and L11. Ishizuka’s
group demonstrated that dFMR1 is a component of the
RISC eﬀector complex and is associated with Dicer and
Ago2[55].KnockdownofdFMR1byintroductionofdFMR1
dsRNA had only mild eﬀects on the eﬃciency of RNAi
[55, 119].
The work of Jin et al [120] suggested that FMRP could
interact with miRNAs, Dicer, and Ago1 in mammalian cells
in vivo, raising the possibility that FMRP could use miRNAs
to regulate translation of speciﬁc mRNAs. Indeed, a recent
study from our laboratory showed that human FMRP can
act as an miRNA acceptor protein for Dicer and facilitate
the assembly of miRNAs on speciﬁc target RNA sequences
[121]. This activity appears to be mediated by the KH do-
mains. In this study, the requirement of FMRP for eﬃcient
RNAi in vivo was unveiled by reporter gene silencing as-
saysusingvarioussmallRNAinducers,whichalsosupported
its involvement in an ss siRNP eﬀector complex in mam-
malian cells. These results deﬁned a possible role for FMRP
in miRNA-guided RNA silencing and provided further in-
sight into the molecular defects in patients with the fragile X
syndrome.
VIG
The VIG protein has been shown to be associated with the
Drosophila RISC [119]. An evolutionarily conserved protein
expressed in Ce l e g a n s , A thaliana, Sp o m b e , and mammals,
VIG has no recognizable protein domains other than an
RGG box, a motif that is known to bind RNA. Although no
function has been assigned to VIG, its human homologue,
plasminogen activator inhibitor (PAI)-RBP-1, was originally
identiﬁedasaproteinhavinganaﬃnityforAU-richelements
(ARE) located in the 3 NTR of PAI RNA and regulating its
stability [122]. The authors also demonstrated the impor-
tance of Dicer and miR-16, a human miRNA containing a
sequence complementary to ARE, in conferring instability to
ARE-containing mRNAs. This suggests an interesting con-
nectionbetweenthecomponentsofthemiRNA-guidedRNA
silencing pathway and regulation of the stability of mRNAs
containing AREs, which are known to act in cis to regulate
rapidturnoverofunstablemRNAs[123]intheir3 NTR.The
exact role of VIG in that context remains to be investigated.
Tudor-SN
The staphylococcal nuclease Tudor (Tudor-SN) has been
identiﬁed as a component of the RISC in C elegans, D mela-
nogaster, and humans [124]. Tudor-SN contains ﬁve staphy-
lococcal/micrococcal domains and a tudor domain. At ﬁrst,
Tudor-SN was suspected to be the nuclease responsible for
the RISC-mediated mRNA target cleavage. However, studies
demonstratingthatthenucleaseactivityoftheRISCisMg2+-
dependent [106]a n dp r o d u c e s5  -phosphomonoester ends
[125] did not support this hypothesis, as Tudor-SN is rather
aC a 2+-dependant nuclease that generates 3 -phosphomono-
and dinucleotides from DNA or RNA substrates [126].
Recently, a novel relationship was established between
Tudor-SN and adenosine deaminases that act on RNA
(ADARs). Members of the ADAR family exhibit aﬃnity with
dsRNAs and mediate an RNA editing reaction that substi-
tutes adenosine (A) residues by inosines (I) in cellular mR-
NAs or other dsRNA targets [127]. Scadden [128] showed
that Tudor-SN speciﬁcally interacts with and promotes the
cleavage of model hyper-edited dsRNA substrates containing
multiple IU and UI pairs. Yang et al [129]h a v er e c e n t l yr e -
ported that the edition of pri-miR-142 resulted in the sup-
pression of its processing by Drosha, and was instead de-
graded by Tudor-SN. Similarly, pre-miRNAs have also been
shown to be edited by ADARs [130]. ADAR-induced modiﬁ-
cation of pri- and pre-miRNA sequences may also contribute
to diversifying and inﬂuencing the genetic control mediated
by miRNAs. For example, structural changes induced by A-
to-Ieditionofpri-andpre-miRNAsmayhampertheirrecog-
nition and processing by the dsRNA-cleaving Drosha and
Dicer RNases [131–133]. These studies reveal a new function
for RNA editing in the control of miRNA biogenesis.
RITScomplex
IntheﬁssionyeastSpombe,dsRNAarisingfromcentromeric
repeatstargetstheformationandmaintenanceofcentromere
function through RNAi-mediated histone H3 lysine-9 (K9)
methylation [90]. This is accomplished by the eﬀector com-
plex RITS, which contains the proteins Ago1, Chp1, and
Tas3, in addition to small RNAs [96] generated by Dicer
[134].Homologoustocentromericrepeats[135],thesesmall
RNAs appear to guide the RITS components to heterochro-
matic regions, such as the centromeres, the mating-type re-
gion, and the telomeres [136, 137]. Upon centromeric bind-
ing, RITS promotes Clr4-mediated methylation of histone
H3 K9, recruitment of Swi6 [138], and formation of hete-
rochromatin [96].Recently,astudyconcludedthatDicerand
the RNAi machinery were involved in the formation of het-
erochromatin in higher vertebrate cells, as suggested previ-
ously [134]. The discovery of the eﬀector RITS complex sup-
ports a nuclear function for small RNAs derived from Dicer.Dominique L. Ouellet et al 9
IDENTIFICATION OF miRNAs AND THEIR TARGETS
As the major protein components of the miRNA-guided
RNA silencing pathway are being identiﬁed and character-
ized, hundreds of new miRNAs are being discovered in sev-
eral diﬀerent species. The fact that the interaction between
miRNAs and the mRNA targets they regulate is based mainly
on partial, rather than perfect, complementarity renders tar-
get idenﬁcation rather arduous. However, improvement of
our understanding of the determinants governing mRNA
recognition by miRNAs has allowed the development of sev-
eral predictive bioinformatic tools. The growing number of
miRNA targets and functions, as revealed by various exper-
imental approaches, let us foresee the importance and com-
plexity of the gene regulatory network utilizing miRNAs.
IdentiﬁcationofmiRNAs
Almost 8 years after the discovery of the ncRNA lin-4,
known for its crucial role in developmental timing in Ce l -
egans [3, 5], three independent groups deﬁned miRNAs as a
novel family of small (∼22nt) regulatory RNAs that are di-
verseinsequenceandexpressionpatterns,andevolutionarily
widespread [10–12]. The authors used diﬀerent strategies to
identify new miRNAs from various species. miRNAs show-
ing features reminiscent of Dicer cleavage can be cloned by
reverse transcription-polymerase chain reaction (RT-PCR)
on size-fractionated RNA populations. If their sequences are
known or predicted, and if they are abundant enough, miR-
NAs can be detected by Northern blot analysis.
Rapid and large-scale identiﬁcation of miRNAs prompt-
ed experts in the ﬁeld to establish guidelines for miRNA an-
notation and institute diﬀerent criteria, based on expression
and biogenesis, for an RNA to be considered as an miRNA
[139]. First, a 22nt RNA transcript must be detected by
Northern blot analysis. Second, the RNA transcript must be
detected in a cDNA library prepared from size-fractionated
RNA samples. Third, bioinformatic analyses must predict a
hairpin-loop structure encoded in the genome and the se-
quence has to be located on one arm of this structure with a
lowest free energy. The hairpin should have small bulges and
approximately 60–80nt in length. Phylogenetic conservation
among species represents another important feature which,
however, excludes miRNAs that have either disappeared, ap-
peared, or evolved during the course of evolution.
Computational algorithms designed to identify hairpin-
loop structures and sequence conservations across species
are very useful, especially for less abundant or tissue-speciﬁc
miRNAs. These small RNAs can be regrouped into families,
based on the sequence of their 5  region [139]. One compu-
tational algorithm that has been developed and tested with
Ce l e g a n s , miRScan, uses diﬀerent characteristics to identify
miRNA genes. It has been designed to ﬁnd conserved se-
quences upstream and downstream of the miRNA foldback,
identify speciﬁc adjacent sequences that can be involved in
miRNA transcription or processing, and determine the lo-
cation of cotranscribed miRNAs in orthologous host genes
[140].
miRBase is the new home of the miRNA data on the web,
accessible at the following address: http://microrna.sanger
.ac.uk/ [141]. It provides information previously accessible
from the miRNA registry [142]. As of May 2006 (release 8.1),
there were 462 human miRNA sequences among 3963 en-
tries.
To date, miRNA genes constitute about 2% of the pre-
dicted genes in mammals. They may be constitutively or
developmentally regulated and expressed at various levels
in diﬀerent tissues. Recent estimates suggest that between
30% and 50% of the genes may be regulated by miRNAs
[144,145].Thisraisesthepossibilitythatallthecellularpath-
ways may be governed by miRNAs. However, the question
remains: which mRNAs are subjected to miRNA regulation?
IdentiﬁcationofmiRNAtargets
Identiﬁcation of miRNA targets is a key step in under-
standing the biological function of miRNAs. However, the
progress of this work is hampered by the mode of mRNA
recognition by the regulatory miRNAs itself, which is based
on imperfect sequence complementarity [25]. Characteriza-
tion of a few experimentally validated miRNA:mRNA inter-
actions allowed to establish a context in which this interac-
tion is favored and helped to develop very useful bioinfor-
matic approaches to identify them. Initial studies indicate
that a given miRNA may regulate several diﬀerent mRNAs
and that, conversely, a speciﬁc mRNA can be regulated by
more than one miRNAs.
Several algorithms currently available on the web,
such as TargetScan (http://genes.mit.edu/targetscan/)[ 146],
Miranda (http://www.microrna.org)[ 147], and DIANA-
microT (http://www.diana.pcbi.upenn.edu/)[ 148], com-
bine diﬀerent parameters of the sequence requirements for
miRNA:mRNAbindingaspredictivemethodstoidentifytar-
gets. These computational tools are designed to scan the
3 NTR of mRNA targets, to search for the miRNA seed and
to determine the free energy of the interaction. They can
also take into account the phylogenetic conservation and
the presence of more than one miRNA binding site in a
given 3 NTR. Because each of these methods uses diﬀer-
entmiRNA:mRNAtargetpredictivedeterminants,theresults
obtained may diﬀer from one to another. Nevertheless, these
bioinformatic tools are crucial in providing initial cues as
to the possible mRNA targets regulated by speciﬁc miRNAs.
They also oﬀer a certain basis for initiating experimental val-
idation on miRNA:mRNA target pair of interest. In turn, a
better comprehension of the interaction between miRNAs
and their targets will permit the improvement of these pre-
dictive methods.
Vella et al [143, 149] studied the well-characterized let-
7:lin-41interactiontobetterunderstandthearchitectureand
requirementsofmiRNA:mRNAtargetrecognition.Although
the lin-41 mRNA target bears six putative let-7 miRNA bind-
ing sites, only two of them appear to be necessary for lin-
41 regulation (see Figure 3). These two sites are separated
by a 27nt sequence. Generally, the miRNA seed consists in
a perfect pairing between miRNA nucleotides 2 to 8 with a10 Journal of Biomedicine and Biotechnology
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Figure 3: Recognition of the lin-41 mRNA by let-7 in C elegans. The lin-41 3 NTR contains two let-7 complementary sites (LCS) separated
by a 27nt sequence that seems to be important in target recognition [143]. The miRNA seed consists in a perfect pairing of nucleotides 2 to
8o ft h em i R N A .
sequence located in the 3 NTR of its mRNA target. Although
pairing of the 3  region of an miRNA seems to be less impor-
tant, it may compensate a weaker binding of the 5  region.
The authors also observed that lin-41 regulation by let-7 was
lost upon substitution of the intervening 27nt sequence by
another[143].ThissuggeststhatmiRNA:mRNAinteractions
donotrelysolelyontheregionsofcomplementarityandmay
be more complex than previously thought.
In spite of the diﬃculties to identify miRNA targets, sev-
eral groups have found their way to assign a biological func-
tion to some miRNAs. Hematopoietic cell lineages derived
from mouse bone marrow express speciﬁc miRNAs that reg-
ulate diﬀerentiation. Chen et al [150] analyzed three miR-
NAs, miR-181, miR-223, and miR-142 that were diﬀeren-
tially or preferentially expressed in hematopoietic cells. They
observed that overexpression of these miRNAs in undiﬀer-
entiated progenitor cells derived from mouse bone marrow
altered lineage diﬀerentiation. They further analyzed the ef-
fects of miR-181 in vivo by infecting mouse Lin− bone mar-
row cells with a viral vector expressing this miRNA and
observed that mice expressing miR-181 had a substantial
increase in B-lymphoid (CD19+)c e l l s .L i me ta l [ 73] used
a microarray approach to identify miRNA targets after over-
expression of known miRNAs. They found that 174 genes
were downregulated following overexpression of miR-124,
anmiRNApreferentiallyexpressedinthebrain,inHeLacells.
Incidentally, the target genes were expressed at low levels in
the brain. Thus, the expression of miR-124 in HeLa cells
caused a shift in gene expression proﬁle towards that of the
brain. Using the same approach, expression in HeLa cells of
miR-1, expressed in muscle, shifted the expression proﬁle of
HeLa cells towards that of the muscle.
BIOLOGICAL FUNCTION OF miRNAs
As experimental evidences are accumulating on how miR-
NAsrecognizeandregulatespeciﬁcmRNAtargets,wearebe-
ginning to understand the exact function of each miRNA as
well as the cellular processes they are regulating. Information
pertaining to the biological function of miRNAs in diﬀerent
species, which is the subject of this section, is summarized in
Table 2.
miRNAsanddevelopment
Developmental studies of the nematode Ce l e g a n sled to the
discovery of the ﬁrst small noncoding regulatory RNA, lin-4.
Ce l e g a n sproceeds through four larval development stages
termed L1 to L4. Transition from one stage to the next is
dictated by temporally regulated heterochronic genes, which
are involved in developmental regulatory cascades. Wight-
man et al [4] ﬁrst reported that short repetitive sequences
in the 3 NTR of the heterochronic gene lin-14 were negative
regulatory elements of Lin-14 expression. The observed in-
crease in Lin-14 protein synthesis associated with two gain-
of-function mutations in the 3 N T Ro fl i n - 1 4m R N A[ 4]w a s
instrumental for this discovery. More than two years later,
Lee et al [3] identiﬁed two lin-4 transcripts, one of 61nt and
another of 21nt. Furthermore, they observed that the lin-4
smaller transcript was complementary to seven repeated se-
quences in lin-14 3 NTR, identiﬁed previously by Wightman
et al [4]. These ﬁndings suggested that lin-4 could regulate
lin-14 translation via an antisense RNA:mRNA interaction
[3]. Recently, Boehm and Slack [169] found that lin-4 and
lin-14 expression control life span through adulthood, since
lin-4 loss-of-function mutant is associated with a shorter life
span as compared to wild-type nematodes, whereas overex-
pression of lin-4 prolonged it. They also noted that animals
carrying a temperature-sensitive loss-of-function mutation
in lin-14 had a 31% longer life span than wild-type, which is
consistent with the phenotype observed with lin-4 [169].
A second small ncRNA, let-7, was later identiﬁed and
found also to regulate the transition from late larval L4 to
adult stage through the regulation of heterochronic genesDominique L. Ouellet et al 11
Table 2: Biological functions of miRNAs in diﬀerent species.
Species Expression miRNA mRNA Validation Mode of Process regulated References
target (Expt/Pred) regulation
Schizosaccharomyces — 12 diﬀerent Centromeric Expt H3 K9 DNA Maintenance of
pombe small RNAs regions methylation heterochromatin
[135]
Caenorhabditis
elegans lin-4 lin-14
lin-28 Expt
Translational Control of the
— repression/ developmental [3, 4, 75, 151]
mRNA cleavage stages L1-L3
—l e t - 7
hbl-1
Expt
Translational
repression/
mRNA cleavage
Control of the last
developmental
stage L4
[75, 149, 152–
156]
lin-41
daf-12
ras
miR-48
hbl-1 Expt Translational
repression
Control of
the L2 to L3
transition
—m i R - 8 4 [ 157]
miR-241
Drosophila — bantam hid Expt Translational Inhibition
melanogaster repression of apoptosis
[158]
miR-2
Inhibition of
apoptosis
miR-6
—m i R - 1 1 N D E x p t N D [ 159]
miR-13
miR-308
Mus musculus Hematopoietic
cells
miR-142
Hematopoietic cell
diﬀerentiation miR-181 ND Expt ND [150]
miR-223
Mouse embryo
< day 7 miR-196 HOXB8 Expt mRNA cleavage
Control of the
developmental [74]
program
Homo sapiens Brain miR-124 ND Expt ND Brain-speciﬁc
gene expression
[73]
Muscle miR-1 ND Expt ND Muscle-speciﬁc
gene expression
[73]
Overexpression
Inhibition of
apoptosis in brain tumor miR-21 ND Expt ND [160]
glioblastoma
Downregulation miR-15a Bcl2 Expt Translational Induction of [161, 162]
in CLL miR-16-1 repression apoptosis
Downregulation in
miR-143
miR-145 numerous cancer ND Expt ND Oncogenesis [163]
cultured cells
Overexpression in miR-155 ND Expt ND Oncogenesis
BL patient
[164]
Overexpression in
miR-17-92
cluster ND Expt ND Oncogenesis B-cells lymphomas
and lung cancer
cell lines
[165]12 Journal of Biomedicine and Biotechnology
Table 2: Continued.
ORF2 in the
Restriction of
PFV-1
accumulation
3 NTR of all
HeLa, 293T miR-32 remaining Expt ND [166]
PFV-1
mRNAs
Liver-speciﬁc
expression
5  noncoding
Facilitation of
HCV replication miR-122 region of the Expt ND [167]
HCV genome
Tc e l l s miR-29a nef Pred ND Inhibition of HIV-1
miR-29b replication
[168]
Control of the cell
T cells miR-149 vpr Pred ND cycle arrest [168]
in G2
T cells miR-378 env Pred ND Control of the virus
assembly
[168]
Control of
T cells miR-324-5p vif Pred ND viral particle [168]
production
BL: Burkitt lymphoma; CLL: chronic lymphocytic leukemias; Expt: experimental; HCV: hepatitis C virus; HIV-1: human immunodeﬁciency virus type 1;
ND: not determined; PFV-1: primate foamy virus type 1; Pred: predicted.
in Ce l e g a n s[152]. Northern blot analyses revealed that the
miRNA let-7 is expressed in a wide range of species, includ-
ing worm, ﬂy, and human, as opposed to lin-4, and seems
to regulate late developmental transition in diﬀerent species
[153]. Three let-7 miRNA family members, miR-48, miR-84,
and miR-241, were identiﬁed on the basis of sequence iden-
tity of 8 consecutive nucleotides in their 5  region [11, 170].
let-7 regulates lin-41, hbl-1, and daf-12 [149, 152–155]. The
other members of the let-7 family appear to regulate hbl-
1 in the L2 to L3 transition [157]. let-7 also appears to be
important for zebraﬁsh embryo development, since injec-
tion of a synthetic let-7 miRNA duplex into zebraﬁsh zygotes
causes severe growth defect [171]. Embryos of a maternal-
zygotic zebraﬁsh Dicer mutant that were unable to process
pre-miRNA into miRNA showed abnormal brain morpho-
genesis [172]. This brain defect was rescued by the injection
of a preprocessed, mature miRNA, miR-430. The miRNA ex-
pression proﬁle of zebraﬁsh embryos is highly tissue-speciﬁc
during segmentation and later stages, but not in early devel-
opment, suggesting that miRNAs may play a more promi-
nent role in diﬀerentiation or maintenance of tissue identity,
rather than in directing tissue fate [173].
miRNAs have also a major role in developmental reg-
ulation in ﬂy. This conclusion came from miRNA loss-of-
function analyses using 2  O-methyl (Me) antisense oligori-
bonucleotides in Drosophila embryos [159]. In these anal-
yses, depletion of as many as 25 of 47 miRNAs expressed
in early development caused a severe developmental pheno-
type. Insitu hybridization analyses,using probes recognizing
38 diﬀerent miRNAs in Drosophila embryos, indicated that
the expression proﬁle of most of them is comparable to their
vertebrate counterparts [174], suggesting an evolutionarily
conserved role for miRNAs in development.
Recently, two groups independently reported the cloning
of the mouse and chicken homologues of C elegans lin-41
[175, 176]. They found that mlin-41 and clin-41 are im-
plicated in limb development. Bioinformatic analyses con-
ﬁrmed the presence of let-7 binding sites in the 3 NTR of
these two genes. In mice, targeted disruption of the Dicer1
gene was lethal in early development, indicating that Dicer
function is essential for proper development in mammals
[50]. Harfe et al [177] used an inducible inactivation sys-
tem of Dicer1 to study its importance in late development in
mice. In this model, depletion of Dicer led to a severe defect
in limb formation.
miRNAsandheterochromatin
The RNAi pathway was also reported to play a role in nuclear
events such as genome rearrangement [178], gene inhibition
[90, 134, 179], and chromosome segregation [134], support-
ing the idea that the genome integrity itself is preserved by
small regulatory RNAs. In a model proposed by Noma et
al [136], dsRNA transcripts are cleaved by Dicer to produce
siRNAs, which are incorporated into the RITS complex and
guide it to heterochromatic regions, probably through inter-
actions with DNA or native RNA transcripts. Once localized
at the siRNA homologous target sequence, the RITS com-
plexrecruitstheClr4methyltransferasethatcatalyzesmethy-
lation of histone H3 at lysine 9. This creates binding sites
for the heterochromatin protein Swi6 which, in turn, leads
to the recruitment of additional Clr4 and further H3-Lys9Dominique L. Ouellet et al 13
methylation of adjacent nucleosomes. These modiﬁcations
allow the binding of RITS in a Dicer-independant manner
via the chromodomain of Chp1 and the maintenance of gene
repression at the transcriptional level. Although this pro-
cess was ﬁrst documented in Sp o m b e[96, 136, 180], re-
cent reports indicate the occurrence of a similar transcrip-
tional gene silencing phenomenon in the nucleus of human
cells [181, 182]. Altogether, these studies reveal a key role for
Dicer-derived small RNAs in guiding the RITS complex and
regulating the transcriptional and posttranscriptional status
of host gene expression.
miRNAsincellgrowthandapoptosis
Cell growth and programmed cell death are important pro-
cesses implicated in both development and diﬀerentiation.
ThebantamgeneidentiﬁedinDrosophilawasﬁrstdiscovered
on the basis of its eﬀect on tissue growth: tissues were larger
when bantam was overexpressed and smaller when bantam
expression was suppressed. Although smaller, the ﬂies were
proportional and did not exhibit patterning defects [158].
Later, the same group determined that the bantam gene en-
coded for an miRNA, not for a protein, that controlled the
proapoptotic gene hid.T h u s ,bantam promotes prolifera-
tionwhileinhibitingapoptosis[183].AdditionalmiRNAsin-
volved in the regulation of pro-apoptotic genes in Drosophila
werediscoveredinloss-of-functionexperiments.Inthatcon-
text, a family of miRNAs comprising miR-2, miR-6, miR-11,
miR-13, and miR-308 has been found to be required for sup-
pression of embryonic apoptosis [159].
Chang et al [184] used a library of miRNA antisense
oligonucleotides bearing 2  O-Me modiﬁcations to inhibit
miRNA function in HeLa cells. Monitoring changes in cell
growth and apoptosis, they identiﬁed several important reg-
ulatory miRNAs. In the highly malignant human brain tu-
morglioblastoma,miR-21wasstronglyoverexpressed.When
miR-21 was knocked down in glioblastoma cultured cells,
caspases were activated, causing an increase in cell apopto-
sis [160]. This suggests a role for miR-21 as a suppressor of
apoptosis in this malignant tumor [160]. In chronic lym-
phocytic leukemias (CLL), the antiapoptotic protein B-cell
lymphoma 2 (Bcl2) is overexpressed [161]. Interestingly, fre-
quent deletions and downregulation of the miR-15 and miR-
16 genes at the chromosome locus 13q14 are observed in
the majority of CLLs [162]. These ﬁndings suggest a role for
miR-15a and miR16-1 as repressors of Bcl2 expression and
possible inducers of apoptosis [161].
RELATIONSHIP BETWEEN miRNAs
AND DISEASES
Given their recognized importance in gene regulation, a link
between miRNAs and several major diseases is expected. For
example, defects in miRNA-mediated regulation of mRNA
translation may lead to overexpression of speciﬁc proteins,
which accumulation may cause diseases. In fact, intriguing
connections between miRNAs and diseases, such as cancer
and viral infections, are emerging.
miRNAsandcancer
A recent study reported that human miRNA genes are fre-
quently located at fragile sites and genomic regions involved
in cancer [185]. Indeed, Calin et al [162] observed frequent
deletions and downregulation of miR-15 and miR-16 genes
at 13q14 in CLL. These miRNAs have been shown to nega-
tively regulate the antiapoptotic Bcl2 protein at the posttran-
scriptional level [161]. BCL2 repression by these miRNAs in-
ducedapoptopsisinaleukemiccelllinemodel[161],thereby
providing a link between the absence of miR-15/miR-16 and
leukemia.
Northern blot analyses showed that miR-143 and miR-
145 expression is downregulated in various human cell lines
derived from breast, prostate, cervical, lymphoid cancers,
and, particularly, colorectal tumors [163]. Potential targets
of these miRNAs have been previously implicated in oncoge-
nesis [163].
A relationship between miRNAs and Burkitt lymphoma
(BL) has been suggested. miR-155 is encoded within nu-
cleotides 241–262 of the BIC gene, which is located on chro-
mosome 21. Both the BIC and miR-155 genes are overex-
pressed in some BL patients, but not in all BL cases [164,
186]. Abnormal miRNA expression may thus contribute to
the transformation of B cells [164].
Another miRNA cluster, miR-17-92, is often overex-
pressed in tumor samples from B-cell lymphomas when
compared to normal cell lines [165]. This cluster is present
in an ampliﬁed DNA region encoding for the ORF c13orf25.
Alignment of this ORF between mouse and human indi-
cates that the polycistron and its immediate ﬂanking se-
quences only are conserved. The c13orf25 transcript con-
tains seven pre-miRNAs encoding for miR-17-5p, miR-17-
3p, miR-18, miR-19a, miR-20, miR-19b-1, and miR-92-1.
Usingamicroarrayanalysisof191maturemiRNAs,ﬁvemiR-
NAs from the cluster were found to be highly expressed in B-
cell lymphomas, in correlation with an increased expression
of c13orf25 [165]. These studies revealed that the miR-17-92
cluster can act as a potential human oncogene, and was re-
ferred as oncomiR-1 by Hammond and colleagues [165].
Another group subsequently reported that the miR-17-
92 cluster was overexpressed in human lung cancer cell lines
[187]. When analyzing the subcellular localization of the
c13orf25 transcript, they observed a nuclear localization,
restricting its cytoplasmic localization for translation. This
suggested that this transcript can act as a vehicle for the ex-
pression of the miR-17-92 cluster. Its predicted targets in-
clude the tumor suppressor genes PTEN and RB2 [146]. In a
mouse B-cell lymphoma model, the overexpression of miR-
17-92 accelerates tumor formation induced by the product
of the MYC gene [165], which encodes an important tran-
scription factor that regulates cell proliferation, growth, and
apoptosis. Modiﬁcation of MYC expression is a commonly
observed deregulation leading to tumorigenesis. O’Donnell
et al showed that c-myc, through binding to sequences near
the miR-17-92 cluster genomic locus, activates miR-17-92
expression [188]. Among the predicted targets of the miR-
17-92 cluster is the transcription factor E2F1, which appears
to be negatively regulated by miR-17-5p and miR-20a [146].14 Journal of Biomedicine and Biotechnology
E2F1isacellcyclepromoterinduceduponc-mycexpression.
Conversely, c-myc expression is induced by E2F1 [189–191].
Therefore, a balance between the gene regulatory processes
involving miRNAs and transcription factors may contribute
to ﬁnely tune E2F1 expression and to generate a tightly con-
trolled proliferative signal [188].
The let-7 miRNA also seems to be involved in cancer
pathogenesis. Calin et al reported that let-7 genesare deleted
inmanycancers[185]. Moreover, a reduction in let-7 expres-
s i o nh a sb e e no b s e r v e di ns a m p l e so fh u m a nl u n gc a n c e r so r
cancer cell lines. Patients associated with a reduced let-7 ex-
pression had the worst prognosis after a potentially curative
resection [192]. It is relevant to note that the overexpression
of let-7 in lung cancer cells inhibits growth in vitro [192]. In
Ce l e g a n s , let-60, the ortholog of the human oncogene RAS,
was found to contain eight putative let-7 binding sites in its
3 NTR [156]. As for the three human RAS genes, they also
containmultiplelet-7bindingsites,allowinglet-7toregulate
RAS expression. Evidences of a downregulatory role for let-
7 in RAS expression came from experiments using reporter
genes fused to the 3 NTR of NRAS and KRAS [156]. Intro-
duction of let-7a inhibitors relieved this repression [156]. In
this study, miRNA microarray analyses of 21 diﬀerent sam-
ples from lung cancer patients revealed that the expression of
the let-7 gene family was reduced, in association with an in-
creased expression of RAS protein. These data suggest a role
for the let-7 miRNA family in the regulation of RAS during
development of lung cancer [156].
Deregulated expression of protein components of the
miRNA biosynthetic pathway may also be implicated in
cancer formation. Karube et al [193] recently observed a
diminution of Dicer expression in nonsmall cell lung can-
cer samples taken from 67 patients, as assessed by RT-PCR.
As for the let-7 miRNA, this reduction was also associated
with shorter postoperative survival [193]. Thus, the presence
of Dicer, which mediates miRNA biogenesis, appears to be
required for maintaining normal cell function.
miRNA expression proﬁling of the aﬀected tissues may
eventually be important for improving the diagnosis of dis-
eases, such as cancer [194]. Using a new miRNA proﬁl-
ing method, Lu et al [195] analyzed mammalian miRNAs
from 334 samples, including human cancers. They observed
a characteristic general downregulation of miRNA expres-
sion in tumors, as compared to normal tissues [195]. Sim-
ilarly, Jiang et al used an RT-PCR approach using primers
speciﬁc to 222 pre-miRNAs to monitor their expression in
human cancer cell lines [196]. Monitoring of global changes
in miRNA expression proﬁles will be useful to establish pos-
sible links between miRNAs and diseases.
miRNAsandviruses
Several studies have reported a role for RNA silencing in host
defense mechanisms against viruses in plants [197], and re-
ports suggest that they may also play a similar role in hu-
mans. The interaction between RNA silencing pathways and
viruses, such as HIV-1, is complex and multifaceted [198].
Some viral RNAs exhibit secondary structures that are prone
toDicerprocessing,asevidencedbythediscoveryofmiRNAs
derived from Epstein-Barr virus (EBV), a virus belonging to
the herpesvirus family, in infected Burkitt’s lymphoma cells
[199]. In this case, miRNAs originate from ﬁve precursors
present in two diﬀerent clusters of the genome of EBV [199].
TheoverallimpactofviralmiRNAsoncellularandviralgene
expression remains to be fully appreciated. They may target
and regulate speciﬁc human mRNAs, thereby ultimately in-
ﬂuencing cell function and viral replication. Indeed, the po-
tential host mRNA targets of these miRNAs, as predicted by
bioinformatical analyses, are implicated in many biological
processes, such as transcription, cell proliferation, apoptosis,
B cell-speciﬁc chemokine and cytokine synthesis, and signal
transduction[199].Theseﬁndingsillustratehowavirusmay
exploit the RNA silencing machinery for its own purpose.
miRNAs derived from a virus may also be turned against
someofitsmRNAs,asexempliﬁedbymiR-BART2.ThisEBV
miRNA has been shown to be perfectly complementary to
the EBV gene BALF5, encoding for a DNA polymerase, and
to target it for degradation [199, 200].
The pathogenic human Kaposi’s sarcoma-associated her-
pesvirus (KSHV) was recently shown to encode an array of
11 distinct miRNAs, all of which are expressed at readily de-
tectable levels in latently KSHV infected cells [201]. Com-
puter analysis of potential mRNA host targets for these vi-
ral miRNAs included several mRNAs previously shown to
be downregulated in KSHV-infected cells, suggesting that
KSHV miRNAs play a critical role in the establishment
and/or maintenance of KSHV latent infection [201].
T h eg e n o m eo fH I V - 1e n c o d e sag e n ec a l l e dnef,w h i c h
is located in the 3  region and is overlapping with the LTR.
Omoto et al identiﬁed a nef-derived miRNA, called miR-
N367, produced in cells persistently infected with HIV-1.
This miRNA has been shown to downregulate the transcrip-
tion of the HIV-1 genome in human T cells by targeting the
negative responsive element of its 5 NTR U3 region and the
nef sequence located in the 3 NTR [202, 203]. HIV-1 was
also found to generate an siRNA that can mediate nucleic-
acid-based immunity and to encode a suppressor of RNA si-
lencing in its Tat protein [204].
Additional evidences suggest that viruses have evolved to
take advantage of RNA silencing pathways to enhance the
probability of successful infection. For example, the simian
virus 40 (SV40) genome was found to encode a pre-miRNA
from which two miRNAs can be derived. Expressed at late
times in infection, these miRNAs are perfectly complemen-
tary to the early viral mRNAs, and target those for degrada-
tion [205]. SV40-infected cells show a reduced expression of
viral T antigens, are less sensitive to lysis by cytotoxic T cells,
and trigger less cytokine production [205].
Cellular miRNAs may also play an important role in
virus/host interactions. For example, miR-32 was found to
restrict retrovirus primate foamy virus type 1 (PFV-1) accu-
mulation in human cells [166]. However, PFV-1 may coun-
teract this cellular restriction through expression of Tas, a
protein inhibiting RNA silencing in mammalian cells [166].
Moreover, a study showed that the sequestration of miR-
122, an miRNA highly and speciﬁcally expressed in the liver,Dominique L. Ouellet et al 15
resulted in a marked loss of autonomously replicating hep-
atitis C virus (HCV) RNAs [167]. HCV replication thus ap-
pears to be facilitated by a genetic interaction between miR-
122 and the 5 NTR of the HCV genome, making miR-122 a
potential target for an anti-HCV intervention.
As for a possible regulation of HIV-1 replication by
human miRNAs, computational predictions identiﬁed four
possible HIV-1 targets: the nef gene targeted by miR-29a and
miR-29b, the vpr gene targeted by miR-149, the vpu gene tar-
geted by miR-378, and the vif gene targeted by miR-324-5p
[168].Microarrayproﬁlingconﬁrmedtheexpressionofthese
miRNAs in HIV-1 replication-competent human T lympho-
cytes [168]. Further investigation is required to determine
the biological signiﬁcance of these cellular miRNAs-HIV-1
interactions.
CONCLUSION
miRNAs are now recognized as key regulators of gene ex-
pression. Not surprisingly, causal links between deregula-
tion of miRNA expression and some important genetic dis-
eases are gradually emerging. A better characterization of the
miRNA expression proﬁles observed in various clinical sit-
uations may ultimately be useful to physicians in providing
signatures for speciﬁc tumors or infectious diseases. Further
investigations that aim at elucidating and understanding the
mechanisms involved in miRNA biosynthesis and function
are crucial for the design and development of potentially im-
portant diagnostic tools and new therapeutic strategies.
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